Recommendations made by the PBAC – November 2022

Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) in November 2022 relating to the listing of drugs on the Pharmaceutical Benefits Scheme (PBS).

• November 2022 – PBAC Outcomes (PDF 437KB) – (Word 100KB)
• November 2022 – Consideration of DUSC Report (PDF 33KB) – (Word 114KB)
• November 2022 – Outcome of the discussion of COVID-19 oral treatments (PDF 147KB) – (Word 21KB)